Is Ozempic used for weight loss, and how is it prescribed safely in Europe?

Ozempic for weight loss explained: semaglutide, GLP-1 receptor agonist therapy, eligibility criteria, side effects, and clinical monitoring.

In this episode, we clarify when Ozempic (semaglutide) may be considered in the context of weight management and how medical suitability is assessed under EU prescribing guidance.

You’ll learn:

• How semaglutide works to regulate appetite and blood glucose

• The difference between diabetes and weight management indications

• Typical dosing and gradual titration schedules

• Expected weight reduction ranges observed in clinical studies

• Common side effects such as nausea, vomiting, and gastrointestinal discomfort

• Contraindications, including certain endocrine and gastrointestinal conditions

• Situations where a prescription request may be declined pending blood tests or specialist evaluation

We explain how doctors assess BMI, HbA1c, metabolic risk factors, cardiovascular history, medication interactions, and lifestyle measures during an online consultation in the EU. Ozempic is not suitable for everyone and requires ongoing medical monitoring.

This episode reflects the clinical standards used by Mobi Doctor, where metabolic consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/ozempic-for-weight-loss